« MediaWiki:ContentImporter-wikidoc-postponed.json » : différence entre les versions
|
|
| Ligne 29 : |
Ligne 29 : |
| "Acetylcholinesterase inhibitor", | | "Acetylcholinesterase inhibitor", |
| "Acoustic neuroma", | | "Acoustic neuroma", |
| "Acoustic neuroma natural history, complications \u0026 prognosis" | | "Acoustic neuroma natural history, complications \u0026 prognosis", |
| | "Acoustic reflex" |
| ] | | ] |
Version du 5 octobre 2019 à 11:25
| "(-)-1-Phenyl-2-propylaminopentane" |
| "(-)-1-phenyl-2-propylaminopentane" |
| "(-)-2β-Carbomethoxy-3β-(3,4-dichlorophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane" |
| "(-)-2β-Carbomethoxy-3β-phenyltropane" |
| "(-)-Methyl-1-methyl-4β-(2-naphthyl)piperidine-3β-carboxylate" |
| "11β-hydroxylase deficiency (patient information)" |
| "Abadie's sign of tabes dorsalis" |
| "Abdominal enlargement" |
| "Abdominal pain" |
| "Acanthosis nigricans" |
| "Accommodative insufficiency" |
| "Acid indigestion" |
| "Acute muscle soreness" |
| "Ankle pain and swelling" |
| "Anosmia" |
| "Anxiety" |
| "Abdominal bruit" |
| "16PF Questionnaire" |
| "16 Personality Factors" |
| "1p36 deletion syndrome" |
| "21-Hydroxylase Deficiency social issues" |
| "Neuritis" |
| "List of endocrine diseases" |
| "Abdominal epilepsy" |
| "Abnormal posturing electrocardiogram" |
| "Acetylcholinesterase inhibitor" |
| "Acoustic neuroma" |
| "Acoustic neuroma natural history, complications & prognosis" |
| "Acoustic reflex" |
|
